pilsicainide has been researched along with Hyperpotassemia in 1 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, Y | 1 |
| Fujikawa, H | 1 |
| Shibazaki, S | 1 |
1 other study available for pilsicainide and Hyperpotassemia
| Article | Year |
|---|---|
Pilsicainide intoxication mimicking hyperkalemia effectively managed by prompt diagnosis and emergency haemodialysis.
Topics: Anti-Arrhythmia Agents; Humans; Hyperkalemia; Lidocaine; Poisoning; Renal Dialysis | 2022 |